Aprepitant Capsules and Skyrizi (150 MG Dose)
Determining the interaction of Aprepitant Capsules and Skyrizi (150 MG Dose) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Skyrizi, Skyrizi topical
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant Capsules-Skyrizi Injection
- Aprepitant Capsules-Skyrizi topical
- Aprepitant Capsules-Sleep Aid
- Aprepitant Capsules-Sleep Aid Tablets
- Aprepitant Capsules-Sleepinal
- Aprepitant Capsules-Slo-Niacin
- Skyrizi (150 MG Dose)-Aprepitant Injection
- Skyrizi (150 MG Dose)-Aprepitant Intravenous
- Skyrizi (150 MG Dose)-Aprepitant Oral Suspension
- Skyrizi (150 MG Dose)-Aprepitant/Fosaprepitant Dimeglumine
- Skyrizi (150 MG Dose)-Apresazide
- Skyrizi (150 MG Dose)-Apresoline